<DOC>
	<DOC>NCT00661479</DOC>
	<brief_summary>This exploratory, 12-month, ascending-dose study will evaluate the safety and effects on visual function of a single injection of Brimonidine intravitreal implant in one eye of patients with Retinitis Pigmentosa.</brief_summary>
	<brief_title>An Exploratory Study to Evaluate the Safety of Brimonidine Intravitreal Implant in Patients With Retinitis Pigmentosa</brief_title>
	<detailed_description />
	<mesh_term>Retinitis</mesh_term>
	<mesh_term>Retinitis Pigmentosa</mesh_term>
	<mesh_term>Brimonidine Tartrate</mesh_term>
	<criteria>Retinitis Pigmentosa in both eyes Visual acuity between 20/40 to count fingers Growth of new blood vessels in the eye Any intraocular surgery or laser in either eye in the last 6 months prior to Screening visit or between the Screening visit and Day 1 Any ocular disease that can interfere with diagnosis and or assessment of disease progression Significant nearsightedness HIV Female patients who are pregnant, nursing, or planning pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>